帕金森病的遗传结构
帕金森病是复杂神经退行性疾病,罕见与常见遗传变异共同影响发病风险、起病与进展。已发现20多个基因的突变与本病相关,多具高外显率,常致早发或不典型症状。全基因组关联研究已识别90个独立风险相关变异,但多数来自欧洲血统人群,其他人群的遗传学所知有限,风险变异的生物学功能理解也有限。
要点
- 超20个基因突变与帕金森病相关,多高外显率、常致早发或不典型症状
- 全基因组关联研究已识别90个独立风险相关变异
- 多数风险变异来自欧洲血统人群,其他人群遗传学资料有限
核心结论
- 帕金森病遗传结构复杂,罕见与常见变异共同贡献风险、起病与进展。
- 已识别90个独立风险相关变异,但多来自欧洲血统人群,其他人群所知有限。
- 风险变异的生物学功能理解有限,机器学习、单细胞RNA测序与高通量筛选有望改善。
研究设计与样本
- 综述类:文中未报告系统检索范围与样本量。
主要发现
- 超20个基因的突变与帕金森病相关,多具高外显率,常致早发或不典型症状。
- 全基因组关联研究已识别90个独立风险相关变异。
- 多数风险变异在患者中于欧洲血统人群识别,其他人群遗传学知之较少。
- 已识别风险变异的生物学功能理解有限。
关键数值与推荐
- 全基因组关联研究已识别90个独立风险相关变异。
- 超20个基因突变与帕金森病相关,多高外显率、常致早发或不典型症状。
- 风险变异似邻近已知帕金森病基因与溶酶体相关基因。
临床怎么用
- 解读遗传风险时需注意现有变异数据多来自欧洲血统人群,跨人群外推应谨慎。
局限性
- 文中未报告系统检索范围与样本量。
- 多数遗传数据来自欧洲血统人群,其他人群遗传学资料有限。
- 已识别风险变异的生物学功能理解有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Parkinson's disease is a complex neurodegenerative disorder for which both rare and common genetic variants contribute to disease risk, onset, and progression. Mutations in more than 20 genes have been associated with the disease, most of which are highly penetrant and often cause early onset or atypical symptoms. Although our understanding of the genetic basis of Parkinson's disease has advanced considerably, much remains to be done. Further disease-related common genetic variability remains to be identified and the work in identifying rare risk alleles has only just begun. To date, genome-wide association studies have identified 90 independent risk-associated variants. However, most of them have been identified in patients of European ancestry and we know relatively little of the genetics of Parkinson's disease in other populations. We have a limited understanding of the biological functions of the risk alleles that have been identified, although Parkinson's disease risk variants appear to be in close proximity to known Parkinson's disease genes and lysosomal-related genes. In the past decade, multiple efforts have been made to investigate the genetic architecture of Parkinson's disease, and emerging technologies, such as machine learning, single-cell RNA sequencing, and high-throughput screens, will improve our understanding of genetic risk.
引用
- Blauwendraat C, Nalls MA, Singleton AB, et al. The genetic architecture of Parkinson's disease. Lancet Neurol. 2019. PMID: 31521533. doi:10.1016/S1474-4422(19)30287-X
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。